PNEUMOVAX® 23 (PPV23)

Catch Them. You Can.

PNEUMOVAX® 23 (pneumococcal polysaccharide vaccine)
Prescribing Information [External link]

PNEUMOVAX® 23 (pneumococcal polysaccharide vaccine) is recommended for active immunisation against pneumococcal disease in children aged from 2 years, adolescents and adults.1

Learn more about pneumococcal disease
Learn more about PNEUMOVAX® 23
Learn more about Eligible patients for the NHS Pneumococcal National Immunisation Programme
Learn more about Safety information
Learn more about Stock status and ordering
Learn more about Training and resources

Reference

  1. PNEUMOVAX 23 Summary of Product Characteristics.

Supporting documentation

PNEUMOVAX® 23 (pneumococcal polysaccharide vaccine)
Prescribing Information

By clicking the link above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-PNX-00317 | Date of Preparation: August 2023